PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Over-the-counter medication · Vitamin B7 Supplement

biotin

Also sold as Vitamin B7. This medicine is for people on kidney dialysis.

Data updated 2026-05-15

29,879
FDA reportsModerately reported
OTC
Availability

biotin (Vitamin B7) is an over-the-counter Vitamin B7 Supplement. This medicine is for people on kidney dialysis.

Dialyvite with Zinc is a prescription vitamin supplement. It is designed to improve nutrition in people on kidney dialysis.

View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

This medicine is for people on kidney dialysis.

Common side effects

No common side effects listed.

Key warnings

You should not take this medicine if you are allergic to any of its ingredients.

The sections below are summarized in plain English from biotin's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Dialyvite with Zinc provides essential vitamins and minerals. These nutrients help support overall health. It is especially helpful for people with kidney problems.

How to Take It

Take one tablet each day. You can take it with or without food. Follow your doctor's directions. Swallow the tablet whole with a glass of water.

This is a plain-language summary of biotin's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.

Pregnancy & Breastfeeding

Talk to your doctor if you are pregnant or breastfeeding before taking this medicine. They can advise you on whether it is safe for you and your baby.

This is a plain-language summary of biotin's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

This is a plain-language summary of biotin's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.

Storage

Store at room temperature away from moisture and heat.

Side Effects (from patient reports)

Based on 29,879 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for biotin, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for biotin each year to the FDA Adverse Event Reporting System (FAERS).

-1,00001,0002,0003,0004,000 20042007201020132016201920222025 1,823

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where biotin sits

biotin has more FDA adverse-event reports than 64% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is biotin; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 29,879 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

29,879

Reports Mentioning Death

911

3.0% of reports — not proof of cause

Hospitalization Reports

5,552

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 25,581 (90%)
Male 2,824 (10%)

Age Distribution

0–17 316
18–44 3,334
45–64 7,221
65–74 4,730
75+ 3,518

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FATIGUE 3,046
2 NAUSEA 2,251
3 ALOPECIA 2,193
4 HEADACHE 2,143
6 DIARRHOEA 1,893
7 PAIN 1,703
8 DIZZINESS 1,583
10 ARTHRALGIA 1,426
11 DYSPNOEA 1,404
12 PRURITUS 1,289
13 FALL 1,186
14 PAIN IN EXTREMITY 1,074
15 ASTHENIA 1,068
16 RASH 1,042
17 COUGH 977

Reactions in Death Reports

DEATH 497
NAUSEA 118
DYSPNOEA 111
VOMITING 108
MULTIPLE ORGAN DYSFUNCTION SYNDROME 107
SEPSIS 107
CONSTIPATION 105
GENERAL PHYSICAL HEALTH DETERIORATION 104
CONDITION AGGRAVATED 100
ABDOMINAL DISTENSION 98

Reactions in Hospitalization Reports

FATIGUE 620
NAUSEA 585
DYSPNOEA 500
FALL 495
DIARRHOEA 483
PNEUMONIA 453
PAIN 421
VOMITING 388
HEADACHE 367
DIZZINESS 344

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

You should not take this medicine if you are allergic to any of its ingredients.

Common Questions

What is Dialyvite with Zinc used for?
It is used to improve the nutritional status of kidney dialysis patients.
How often should I take this medicine?
Take one tablet per day.
Can I take this with other medications?
Talk to your doctor or pharmacist before taking it with other medicines.
What should I do if I experience side effects?
Tell your doctor right away if you have any side effects.
Is this medicine safe during pregnancy?
Talk to your doctor if you are pregnant or breastfeeding.
What are the ingredients in Dialyvite with Zinc?
It contains folic acid, vitamin C, thiamine, riboflavin, niacinamide, vitamin B6, vitamin B12, biotin, pantothenic acid, and zinc.
How should I store this medicine?
Store at room temperature away from moisture and heat.
What does 'prescription' mean?
It means you need a doctor's order to get this medicine.
Can I crush or chew the tablet?
No, swallow the tablet whole.
What if I accidentally take too much?
Call your doctor or seek medical attention immediately.
What drug class is biotin?
biotin belongs to the Vitamin B7 Supplement drug class. It is available over the counter (OTC). This medicine is for people on kidney dialysis.
Is biotin safe during pregnancy?
Talk to your doctor if you are pregnant or breastfeeding before taking this medicine. They can advise you on whether it is safe for you and your baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Vitamin B7 Supplement

Other drugs grouped near biotin - same-class peers and common alternatives.

Compare biotin vs ascorbic acid side-by-side →

Medication Guides

What the FDA Data Shows for biotin

The FDA label for biotin (sold under brand names such as Vitamin B7) classifies it as an over-the-counter product in the Vitamin B7 Supplement class. This medicine is for people on kidney dialysis. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 29,879 voluntary reports. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: January 27, 2026

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

All federal data sources used on this page